(Q45260842)

English

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

scientific article published in February 2005

In more languages
default for all languages
No label defined

No description defined

Statements

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit